Pricing Log in Create free account

Alzamend Neuro, Inc. (ALZN) vs Jaguar Animal Health, Inc. (JAGX)

Alzamend Neuro, Inc. and Jaguar Animal Health, Inc. are both Biotechnology companies. Alzamend Neuro, Inc. is the larger, with a market value of $6.3M against $5.3M — 1.2× the size. Alzamend Neuro, Inc. has the higher net margin (0.00% vs −188.5%) and the higher return on invested capital (0.00% vs −28,393.6%). Across the 15 metrics below, Alzamend Neuro, Inc. leads on 10 and Jaguar Animal Health, Inc. on 5.

Valuation

Metric ALZN JAGX Biotechnology median
P/E n/m n/m 11.19
P/S n/m 0.00 9.15
P/B 1.01 0.00 2.23
Price to free cash flow n/m n/m 26.14
EV/EBITDA 0.16 0.14 0.71
EV/Sales n/m (0.12) 8.65
Earnings yield (175.57%) (1,425,993.60%) (33.82%)
Free cash flow yield (121.76%) (34,129.63%) (23.58%)

Profitability

Metric ALZN JAGX Biotechnology median
Gross margin 0.00% 82.31% 68.27%
Operating margin 0.00% (93.10%) 0.00%
Net margin 0.00% (188.46%) 0.00%
Free cash flow margin 0.00% (24.03%) 0.00%
Return on equity (163.23%) (1,125.38%) (50.82%)
Return on assets (122.36%) (127.14%) (46.08%)
Return on invested capital 0.00% (28,393.64%) 0.00%

Growth

Metric ALZN JAGX Biotechnology median
Revenue growth (TTM) — 135.52% 7.42%
EPS growth (last fiscal year) 76.77% 82.42% 29.86%
Revenue growth, 5-year CAGR — 4.17% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALZN JAGX Biotechnology median
Debt to equity 0.00 0.35 0.00
Current ratio 3.01 0.69 4.72
Net debt to EBITDA 0.08 (0.17) 1.01

Dividend

Metric ALZN JAGX Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric ALZN JAGX Biotechnology median
Market cap 6.27m 5.34m 176.65m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack